Next-Generation Diabetic Foot Care Platform
Legal Citation
Summary of the Inventive Concept
A wearable, machine learning-driven system for predicting and preventing diabetic foot ulcers, leveraging advanced PPG signal analysis and real-time feedback to patients and healthcare providers.
Background and Problem Solved
The original patent's apparatus and method for measuring blood flow in the foot, while innovative, have limitations in detecting early signs of diabetic foot complications. The new inventive concept addresses these limitations by introducing a paradigm shift in diabetic foot care, integrating machine learning, real-time monitoring, and personalized treatment plans to prevent ulceration and improve patient outcomes.
Detailed Description of the Inventive Concept
The next-generation diabetic foot care platform comprises a wearable device with embedded PPG sensors, a machine learning module, and a notification system. The device analyzes PPG signals to identify patterns indicative of increased risk of ulceration and alerts patients or healthcare providers in real-time. The platform also integrates electronic health records, medical history, and lifestyle data to generate customized treatment plans. Additionally, the system includes a telemedicine module for remote consultations, enabling timely interventions and improved patient care.
Novelty and Inventive Step
The new claims introduce a novel combination of machine learning, real-time monitoring, and personalized treatment plans, which constitutes a significant departure from the original patent's apparatus and method. The inventive step lies in the integration of these components to create a proactive, patient-centric platform for diabetic foot care.
Alternative Embodiments and Variations
Alternative embodiments of the inventive concept may include handheld devices, smart insoles, or cloud-based analytics platforms. Variations could incorporate additional sensors, such as temperature or pressure sensors, to provide a more comprehensive picture of foot health.
Potential Commercial Applications and Market
The next-generation diabetic foot care platform has significant commercial potential in the healthcare industry, particularly in the fields of diabetes management, wound care, and telemedicine. The platform's ability to prevent ulceration, reduce healthcare costs, and improve patient outcomes positions it for widespread adoption in hospitals, clinics, and patient homes.
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Medical device technology, specifically non-invasive blood flow measurement and diagnostic systems for diabetic foot care, requiring expertise in photoplethysmography (PPG), sensor design, machine learning, and medical signal processing
Person of Ordinary Skill (PHOSITA) Profile
A biomedical engineer or medical device researcher with advanced degrees in bioengineering, electrical engineering, or medical technology, possessing knowledge of sensor integration, signal analysis, and healthcare technology development
Obviousness Rationale
A PHOSITA would recognize that extending the source patent's foot blood flow measurement apparatus to include machine learning-driven predictive analytics and personalized healthcare monitoring represents a natural technological progression. The core PPG sensing technology remains fundamentally consistent, with the primary innovation being the intelligent data processing and communication framework. The integration of electronic health records and real-time notification systems would be considered a predictable application of existing medical monitoring technologies.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,303 |
|---|---|
| Title | Apparatus and method of measuring blood flow in the foot |
| Assignee(s) | Podimetrics, Inc. |